Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2025 · 91 positions · Total reported value $843.13M · Top-10 concentration 33.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Parkman Healthcare Partners LLC disclosed 91 equity positions with a combined reported value of $843.13M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 33.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were PODD ($34.27M), CVS ($33.65M), LLY ($32.37M). By sector, the heaviest allocations are Health Care 83.5%, Consumer Staples 4.0%. Versus the prior quarter, allocation shifted toward Industrials (+3.5pp), Consumer Staples (+2.9pp) and away from Health Care (-1.4pp), Other (-6.1pp).

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions. The portfolio's overlap with the prior quarter was 65% of names.

The largest new positions opened in Q1 2025 were ZBH ($22.69M), BMRN ($19.60M), RVTY ($14.77M).

Of the 13 positions fully exited versus the prior quarter, the largest were ITCI ($20.31M), ABT ($20.02M), BCYC ($4.93M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • ZBH ZIMMER BIOMET HOLDINGS INC · $22.69M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $19.60M
  • RVTY REVVITY INC · $14.77M
  • DHR DANAHER CORP DEL · $12.97M
  • KALV KALVISTA PHARMACEUTICALS INC · $8.70M
  • ANIP ANI PHARMACEUTICALS INC · $7.03M
  • TMCI TREACE MED CONCEPTS INC · $5.99M
  • DOCS DOXIMITY INC · $5.43M

Fully Exited (vs previous quarter)

  • ITCI INTRA-CELLULAR THERAPIES INC · prev qtr: $20.31M
  • ABT ABBOTT LABORATORIES · prev qtr: $20.02M · history
  • BCYC BICYCLE THERAPEUTICS PLC · prev qtr: $4.93M
  • JAZZ JAZZ PHARMACEUTICALS PLC · prev qtr: $4.65M · history
  • TEVA TEVA PHARMACEUTICAL INDS LTD · prev qtr: $4.34M
  • NARI INARI MED INC · prev qtr: $3.94M
  • ETON ETON PHARMACEUTICALS INC · prev qtr: $3.69M
  • ICLR ICON PUB LTD CO · prev qtr: $3.33M

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 77 positions worth $976.83M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 77 positions · $976.83M reported value (Q2 2026)
  • Top 10 holdings = 33.5% of reported value
  • Largest position: MBX (MBX BIOSCIENCES INC COM) at 4.5%
  • Average position size: $12.69M

Sector Tilt

  • Health Care 92.1%
  • Consumer Staples 4.1%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 18 new, 25 added, 30 reduced, 31 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.5%
Technology 0.6%
Other 7.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 130.51K $34.27M 4.07%
4.07%
Add
2 496.74K $33.65M 3.99%
3.99%
Add
3 39.19K $32.37M 3.84%
3.84%
Add
4 77.69K $28.92M 3.43%
3.43%
Hold
5 213.42K $28.70M 3.40%
3.40%
Add
6 120.28K $27.55M 3.27%
3.27%
Add
7 312.65K $26.37M 3.13%
3.13%
Add
8 50.21K $26.30M 3.12%
3.12%
Add
9 218.95K $24.53M 2.91%
2.91%
Reduce
10 225.99K $22.80M 2.70%
2.70%
Reduce
11 200.50K $22.69M 2.69%
2.69%
New
12 277.25K $19.60M 2.33%
2.33%
New
13 168.38K $18.62M 2.21%
2.21%
Add
14 68.94K $18.61M 2.21%
2.21%
Add
15 954.07K $17.10M 2.03%
2.03%
Reduce
16 762.62K $16.94M 2.01%
2.01%
Hold
17 260.42K $16.53M 1.96%
1.96%
Reduce
18 631.24K $15.94M 1.89%
1.89%
Add
19 1.23M $15.04M 1.78%
1.78%
Add
20 22.10K $14.87M 1.76%
1.76%
Reduce
21 139.56K $14.77M 1.75%
1.75%
New
22 200.82K $14.56M 1.73%
1.73%
Add
23 359.64K $14.44M 1.71%
1.71%
Add
24 1.06M $14.35M 1.70%
1.70%
Reduce
25 280.31K $14.28M 1.69%
1.69%
Add
26 63.25K $12.97M 1.54%
1.54%
New
27 2.49M $12.54M 1.49%
1.49%
Reduce
28 304.24K $11.02M 1.31%
1.31%
Add
29 62.59K $10.59M 1.26%
1.26%
Reduce
30 536.83K $9.93M 1.18%
1.18%
Add
31 1.78M $9.77M 1.16%
1.16%
Add
32 1.22M $9.54M 1.13%
1.13%
Reduce
33 481.47K $9.50M 1.13%
1.13%
Reduce
34 425.41K $9.36M 1.11%
1.11%
Add
35 950.40K $9.27M 1.10%
1.10%
Add
36 130.37K $8.90M 1.06%
1.06%
Add
37 753.75K $8.70M 1.03%
1.03%
New
38 1.04M $8.27M 0.98%
0.98%
Add
39 109.99K $7.80M 0.93%
0.93%
Add
40 1.00M $7.50M 0.89%
0.89%
Add
41 594.99K $7.31M 0.87%
0.87%
Add
42 105.00K $7.03M 0.83%
0.83%
New
43 350.55K $7.02M 0.83%
0.83%
Add
44 166.87K $6.55M 0.78%
0.78%
Reduce
45 183.68K $6.42M 0.76%
0.76%
Add
46 713.54K $5.99M 0.71%
0.71%
New
47 174.58K $5.86M 0.69%
0.69%
Reduce
48 93.50K $5.43M 0.64%
0.64%
New
49 22.62K $5.06M 0.60%
0.60%
New
50 166.28K $4.93M 0.58%
0.58%
Add

FAQ

What did Parkman Healthcare Partners LLC buy in 2025-Q1?

In its 2025-Q1 13F filing, Parkman Healthcare Partners LLC reported 91 equity positions worth $843.13M in aggregate; its largest disclosed positions were PODD ($34.27M), CVS ($33.65M), LLY ($32.37M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $843.13M of long equity holdings across 91 positions as of 2025-Q1. Top-10 holdings account for 33.9% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →